Timm Trenktrog

Title: Timm Trenktrog: Innovator in Pharmaceutical Formulations

Introduction

Timm Trenktrog is a notable inventor based in Binningen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 2 patents to his name, Trenktrog's work has the potential to impact patient care and medication delivery.

Latest Patents

Trenktrog's latest patents include the invention of a dispersible bosentan tablet. This invention relates to dispersible tablets comprising the compound 4-tert-butyl-N-[6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-(pyrimidin-2-yl)-pyrimidin-4-yl]-benzenesulfonamide. This formulation aims to enhance the solubility and bioavailability of the medication, making it easier for patients to consume.

Career Highlights

Timm Trenktrog is currently associated with Actelion Pharmaceuticals Ltd., a company known for its focus on innovative treatments for pulmonary arterial hypertension and other serious conditions. His work at Actelion has allowed him to collaborate with leading experts in the pharmaceutical industry and contribute to groundbreaking research.

Collaborations

One of Trenktrog's notable collaborators is Lovelace Holman. Their partnership has fostered a creative environment for developing new pharmaceutical solutions.

Conclusion

Timm Trenktrog's contributions to the pharmaceutical industry through his patents and work at Actelion Pharmaceuticals Ltd. highlight his commitment to innovation in medication delivery. His inventions have the potential to improve patient outcomes and advance the field of pharmaceuticals.